Shenlian Biomedical

Pioneering Life Sciences, Advancing Human Health

Shenlian Biomedical (688098.SH), established in 2001, holds the distinction of being the first animal health company listed on China’s Science and Technology Innovation Board (STAR Market). Dedicated to building a world-class high-tech biotechnology enterprise, the company leverages cutting-edge global innovations to focus on the R&D and industrialization of preventive, therapeutic, and diagnostic products for both livestock and companion animals.
More
2001
Company Established
104
Patent Certificate
15
New Veterinary Drug Registration Certificate
MSG